Toward new therapeutic strategies against neointimal formation in restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 7, 2000, Pages 1699-1700

  Mach, François ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

Author keywords

Editorials; Inflammation; Restenosis; Therapeutic

Indexed keywords

BETA1 INTEGRIN; BLOOD CLOTTING FACTOR; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE ANTIBODY; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1 ANTIBODY;

ARTERY INTIMA PROLIFERATION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MEDICAL LITERATURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033928266     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.7.1699     Document Type: Editorial

References (15)

1. Bittl JA. Advances in coronary angioplasty. N Engl J Med. 1996;335: 1290-1302.
2. Libby P, Ganz P. Restenosis revisited: new targets, new therapies. N Engl J Med. 1997;337:418-419.
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;331:489-495.
4. Schwartz RS, Topol EJ, Serruys PW, Sangiorgi G, Holmes DR Jr. Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol. 1998;32:2087-2094.
5. Lafont A, Topol E, eds. Arterial Remodeling: A Critical Factor in Restenosis. Boston, Mass: Kluwer; 1997.
6. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1002.
7. Anderson H, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation. 1996;93:1716-1724.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
9. Oguchi S, Dimayuga P, Zhu J, Chyu K-Y, Yano J, Shah PK, Nilsson J, Cercek B. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2000;20:1729-1736.
10. Foster CA. VCAM-1/α4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol. 1996;98: S270-S277.
11. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237-1244.
12. Mach F, Schönbeck U, Sukhova GK, Atkinson B, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998; 394:200-203.
13. Duplaa C, Couffinhal T, Dufourcq P, Llanas B, Moreau C, Bonnet J. The integrin very late antigen-4 is expressed in human smooth muscle cells: involvement of α4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res. 1997;80:159-169.
14. Libby P. Gene therapy of restenosis: promise and perils. Circ Res. 1998;82:404-406.
15. Teirstein PS, Massullo V, Jani S, Russo RJ, Cloutier DA, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Norman S, Tripuraneni P. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation. 1999;99:243-247.